Tolvaptan is an aquaretic drug that functions as a selective, competitive vasopressin receptor 2 antagonist used to treat hyponatremia associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone.
JINARC (TOLVAPTAN) INDICATIONS:
Jinarc is a medicine used to treat a disease called “autosomal dominant polycystic kidney disease” (ADPKD). This disease causes growth of fluid-filled cysts in the kidneys which put pressure on surrounding tissues and reduce kidney function, possibly leading to kidney failure. Jinarc is used to treat ADPKD in adults with chronic kidney disease (CKD) stages 1 to 4 with evidence of rapidly progressing disease.
Jinarc contains the active substance tolvaptan which blocks the effect of vasopressin, a hormone involved in the formation of cysts in the kidneys of ADPKD patients. By blocking the effect of vasopressin, Jinarc slows the development of kidney cysts in patients with ADPKD, reduces symptoms of the disease and increases urine production.
DOSAGE FORM & STRENGTH:
Jinarc 15 mgdistributor, supplier, wholesaler
Jinarc 30 mg Wholesale
Jinarc 45 mg
Jinarc 60 mg
Jinarc 90 mg
Rasso Swiss Pharma can supply you with all dosage of Jinarc.